Suicide genes against brain tumors.

Abstract

Human Gene TherapyVol. 9, No. 17 Commentary The Search for the "Best" Cytokine to Induce Antitumor ImmunityFlorence PaillardFlorence PaillardSearch for more papers by this authorPublished Online:6 Jul 2004https://doi.org/10.1089/10430349850019292AboutSectionsPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail "Commentary The Search for the "Best" Cytokine to Induce Antitumor Immunity." , 9(17), pp. 2457–2458FiguresReferencesRelatedDetailsCited byVesicular Stomatitis Virus as an Oncolytic Vector Glen N. Barber15 December 2004 | Viral Immunology, Vol. 17, No. 4Cells as Vehicles for Cancer Gene Therapy: The Missing Link Between Targeted Vectors and Systemic Delivery? Kevin Harrington, Luis Alvarez-Vallina, Marka Crittenden, Michael Gough, Heung Chong, Rosa Maria Diaz, Georges Vassaux, Nicholas Lemoine, and Richard Vile6 July 2004 | Human Gene Therapy, Vol. 13, No. 11Systemic Administration of Naked DNA Encoding Interleukin 12 for the Treatment of Human Papillomavirus DNA-Positive Tumor Vivian Wai Yan Lui, Yukai He, Louis Falo, and Leaf Huang6 July 2004 | Human Gene Therapy, Vol. 13, No. 2Therapeutic Vaccination against Metastatic Carcinoma by Expression-Modulated and Immunomodified Autologous Tumor Cells: A First Clinical Phase I/II Trial Burghardt Wittig, Angela Märten, Tomislav Dorbic, Silvia Weineck, Heshon Min, Sigrun Niemitz, Beate Trojaneck, Dimitri Flieger, Susanne Kruopis, Andreas Albers, Jürgen Löffel, Andreas Neubauer, Peter Albers, Stefan Müller, Tilman Sauerbruch, Thomas Bieber, Dieter Huhn, and Ingo G.H. Schmidt-Wolf6 July 2004 | Human Gene Therapy, Vol. 12, No. 3Immunological Gene Therapy with ex Vivo Gene-Modified Tumor Cells: A Critique and a Reappraisal Giorgio Parmiani, Monica Rodolfo, and Cecilia Melani6 July 2004 | Human Gene Therapy, Vol. 11, No. 9Strategy of liver-directed gene therapy: present status and future prospectsLiver International, Vol. 19, No. 4Heat Shock Protein Expression in Target Cells Infected with Low Levels of Replication-Competent Virus Contributes to the Immunogenicity of Adenoviral Vectors Alan Melcher, Stephen Murphy, and Richard Vile6 July 2004 | Human Gene Therapy, Vol. 10, No. 9Targeting of Therapeutics to the Liver: Liposomes and Viral VectorsAlcoholism: Clinical and Experimental Research, Vol. 23, No. 5Vesicular Stomatitis Virus and RNA Viruses as Gene Therapy Vectors Volume 9Issue 17Nov 1998 To cite this article:Florence Paillard.Commentary The Search for the "Best" Cytokine to Induce Antitumor Immunity.Human Gene Therapy.Nov 1998.2457-2458.http://doi.org/10.1089/10430349850019292Published in Volume: 9 Issue 17: July 6, 2004PDF download